0001193125-20-266430.txt : 20201008 0001193125-20-266430.hdr.sgml : 20201008 20201008172531 ACCESSION NUMBER: 0001193125-20-266430 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201007 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201008 DATE AS OF CHANGE: 20201008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mimecast Ltd CENTRAL INDEX KEY: 0001644675 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37637 FILM NUMBER: 201231574 BUSINESS ADDRESS: STREET 1: 1 FINSBURY AVENUE CITY: LONDON STATE: X0 ZIP: EC2M 2PF BUSINESS PHONE: 44(0)2078478700 MAIL ADDRESS: STREET 1: 1 FINSBURY AVENUE CITY: LONDON STATE: X0 ZIP: EC2M 2PF 8-K 1 d39688d8k.htm 8-K 8-K
Mimecast Ltd 00-0000000 false 0001644675 0001644675 2020-10-07 2020-10-07

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 7, 2020

 

 

MIMECAST LIMITED

(Exact name of registrant as specified in its charter)

 

 

 

Bailiwick of Jersey   001-37637   Not Applicable

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1 Finsbury Avenue

London EC2M 2PF

United Kingdom

(Address of principal executive offices) (Zip code)

(781) 996-5340 Registrant’s telephone number, including area code

Not Applicable

(Former name or former address if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

(Title of each class)

 

(Trading

Symbol)

 

(Name of each exchange

on which registered)

Ordinary Shares, nominal value $0.012 per share   MIME   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 


Item 1.01.

Entry into a Material Definitive Agreement.

On October 7, 2020, the Board of Directors of Mimecast Limited, a company organized under the laws of the Bailiwick of Jersey, the Channel Islands (the “Company”), approved new forms of standard indemnification agreements for the Company’s directors and executive officers (the “Indemnification Agreements”). Under the terms of the Indemnification Agreements, the Company agrees to hold harmless and indemnify directors and executive officers against certain expenses and liabilities properly incurred or paid by such person by reason of such person’s position with the Company to the fullest extent permitted by The Companies (Jersey) Law 1991, with certain limited exceptions. The Indemnification Agreements provide for the advancement of expenses in certain circumstances. The Indemnification Agreements are governed under the laws of the State of Delaware USA. The Company intends to enter an Indemnification Agreement with each of the Company’s existing directors and executive officers.

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the Indemnification Agreements, which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On October 8, 2020, the Company held its 2020 annual general meeting (“AGM”) of shareholders. There were 63,875,547 outstanding ordinary shares entitled to vote at the AGM as of October 6, 2020, the voting record date. At the AGM, the matters on which the shareholders voted, in person or by proxy, were to:

 

  1.

re-elect Christopher FitzGerald as a Class II Director of the Company;

 

  2.

re-elect Neil Murray as a Class II Director of the Company;

 

  3.

re-elect Robert P. Schechter as a Class II Director of the Company;

 

  4.

appoint Ernst & Young LLP in the United Kingdom as independent auditor of the Company to hold office from the conclusion of the AGM until the conclusion of the annual general meeting of the Company to be held in 2021;

 

  5.

authorize the Board of Directors of the Company to determine the remuneration of the independent auditor;

 

  6.

receive the Company’s accounts for the year ended March 31, 2020, together with the independent auditor’s report on those accounts;

 

  7.

approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement delivered to shareholders; and

 

  8.

reauthorize the Board of Directors of the Company to repurchase, and hold as treasury shares upon repurchase, up to 40,000,000 of the Company’s ordinary shares, with such authority expiring on October 7, 2025, as further described in the Proxy Statement delivered to shareholders.


The results of the voting were as follows:

Election of Directors:

 

Director

   Votes For      Votes Against      Votes Withheld      Broker Non-Votes  

Christopher FitzGerald

     38,675,620        8,741,776        41,247        6,516,739  

Neil Murray

     46,896,367        524,281        37,995        6,516,739  

Robert P. Schechter

     46,489,105        924,401        45,137        6,516,739  

Appointment of Ernst & Young LLP in the United Kingdom as Independent Auditor:

 

Votes For

  

Votes Against

  

Votes Withheld

  

Broker Non-Votes

53,931,198    12,512    31,672    0

Authorization to Determine Remuneration of the Independent Auditor:

 

Votes For

  

Votes Against

  

Votes Withheld

  

Broker Non-Votes

53,925,997    13,234    36,151    0

Receipt of Company’s Accounts for the Year Ended March 31, 2020:

 

Votes For

  

Votes Against

  

Votes Withheld

  

Broker Non-Votes

53,192,208    1,437    781,737    0

Approve the Compensation of the Company’s Named Executive Officers:

 

Votes For

  

Votes Against

  

Votes Withheld

  

Broker Non-Votes

43,788,865    3,626,176    43,602    6,516,739

Reauthorization of the Authority to Repurchase Ordinary Shares:

 

Votes For

  

Votes Against

  

Votes Withheld

  

Broker Non-Votes

46,155,813    994,186    308,644    6,516,739

Following the AGM, (i) Aron Ain, Alpna J. Doshi and Stephen M. Ward continue to serve as Class I Directors of the Company and their term expires at the annual general meeting of the Company to be held in 2022; and (ii) Peter Bauer and Hagi Schwartz continue to serve as Class III Directors of the Company and their term expires at the annual general meeting of the Company to be held in 2021.


Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
Number

  

Description

10.1    Form of Director Indemnification Agreement
10.2    Form of Officer Indemnification Agreement
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MIMECAST LIMITED
Dated: October 8, 2020     By:  

/s/ Robert P. Nault

      Robert P. Nault
      Senior Vice President and
      General Counsel
EX-10.1 2 d39688dex101.htm EX-10.1 EX-10.1

Exhibit 10.1

DIRECTOR INDEMNIFICATION AGREEMENT

THIS DIRECTOR INDEMNIFICATION AGREEMENT (this “Agreement”) is made effective as of the      day of                 , 2020, by and between MIMECAST LIMITED, a public limited company incorporated in Jersey, Channel Islands under number 119119 the registered office of which is 22 Grenville Street, St Helier, Jersey JE4 8PX (“Company”) and                                           (the “Indemnitee”).

WHEREAS, it is essential to the Company that it be able to retain and attract as directors the most capable persons available;

WHEREAS, the Company’s Articles of Association (as amended, modified, supplemented or restated from time to time, the “Articles”) and the Companies Law permit (subject to certain limitations) the Company to indemnify its directors and permit the Company to make other indemnification arrangements and agreements;

WHEREAS, the Company desires to provide the Indemnitee with specific contractual assurance of the Indemnitee’s rights to indemnification against certain litigation risks and expenses subject always, and to the extent permitted by, the Companies Law and the Articles and regardless of any change in the composition of its board of directors (the “Board”); and

NOW, THEREFORE, in consideration of the promises and the covenants contained herein, the Company and the Indemnitee do hereby covenant and agree as follows:

1. Definitions and Interpretation.

(a) “Companies Law” means the Companies (Jersey) Law 1991 (as the same may be amended, modified, supplemented or restated from time to time).

(b) “Corporate Status” describes the status of a person who is serving or has served (i) as a director of the Company, (ii) in any capacity with respect to any employee benefit plan of the Company or (iii) as a director of any other Entity at the request of the Company. For purposes of subsection (iii) of this Section l(b), a director of the Company who is serving or has served as a director of a Subsidiary shall be deemed to be serving at the request of the Company.

(c) “Entity” shall mean any corporation, partnership, limited liability company, joint venture, company, foundation, association, organization or other legal entity.

(d) “Expenses” shall mean all fees, costs and expenses properly incurred in connection with any Proceeding, including, without limitation, attorneys’ fees, disbursements and retainers (including, without limitation, any fees, disbursements and retainers properly incurred by the Indemnitee pursuant to Section 10 of this Agreement), fees and disbursements of expert witnesses, private investigators and professional advisors (including, without limitation, accountants and investment bankers), court costs, transcript costs, fees of experts, travel expenses, duplicating, printing and binding costs, telephone and fax transmission charges, postage, delivery services, secretarial services and other disbursements and expenses.

 

1


Exhibit 10.1

 

(e) “Indemnifiable Expenses,” “Indemnifiable Liabilities” and “Indemnifiable Amounts” shall have the meanings ascribed to those terms in Section 3(a) below.

(f) “Liabilities” shall mean judgments, damages, liabilities, losses, penalties, excise taxes, fines and amounts paid in settlement.

(g) “Proceeding” shall mean any threatened or pending claim, action, suit, arbitration, alternate dispute resolution process, investigation, administrative hearing, appeal, or any other proceeding, whether civil, criminal, administrative, arbitrative or investigative, whether formal or informal, including a proceeding initiated by the Indemnitee pursuant to Section 10 of this Agreement to enforce the Indemnitee’s rights hereunder.

(h) “Subsidiary” shall mean any subsidiary of the Company, as defined in the Companies Law.

(i) References to Sections are to sections of this Agreement.

(j) Use of any gender includes the other genders.

(k) Headings and titles are inserted for convenience only and are to be ignored in the interpretation of this Agreement.

(l) If there is any inconsistency between the provisions of this Agreement and the provisions of any contract of employment or terms of appointment in effect on the date of this Agreement between the Indemnitee and the Company (or any Subsidiary), the provisions of this Agreement shall prevail.

2. Services of Indemnitee. In consideration of the Company’s covenants and commitments hereunder, the Indemnitee agrees to serve or continue to serve as a director on the Board. However, this Agreement shall not impose any obligation on the Indemnitee or the Company to continue the Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.

3. Agreement to Indemnify. Subject always to the provisions of this Agreement, the Articles and the Companies Law, the Company hereby agrees to hold harmless and indemnify the Indemnitee against all Expenses and Liabilities properly incurred or paid by the Indemnitee by reason of the Indemnitee’s Corporate Status to the fullest extent permitted by Article 77 of the Companies Law, as amended, and any other applicable law. In furtherance of the foregoing indemnification, and without limiting the generality thereof:

(a) Subject to the exceptions contained in Section 4, Section 6 and Section 8 below, if the Indemnitee was or is a party or is threatened to be made a party to or participant in any Proceeding (other than an action by or in the right of the Company) by reason of the Indemnitee’s Corporate Status, the Indemnitee shall be indemnified and held harmless by the Company against all Expenses and Liabilities properly incurred or paid by the Indemnitee or on the Indemnitee’s behalf in connection with such Proceeding (referred to herein as “Indemnifiable Expenses” and “Indemnifiable Liabilities,” respectively, and collectively as “Indemnifiable Amounts”).

 

2


Exhibit 10.1

 

(b) Subject to the exceptions contained in Section 4, Section 6 and Section 8 below, if the Indemnitee was or is, or is threatened to be made, a party to or participant in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of the Indemnitee’s Corporate Status, the Indemnitee shall be indemnified and held harmless by the Company against all Indemnifiable Expenses.

(c) In addition to, and without regard to any limitations on, the indemnification provided for in Sections 3(a) and (b) but subject to the exceptions contained in Section 4, Section 6 and Section 8 below, the Indemnitee shall be indemnified and held harmless by the Company against all Indemnifiable Amounts if, by reason of the Indemnitee’s Corporate Status, the Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right of the Company) provided that in no circumstances shall the Company be obligated to make any payment to the Indemnitee that it is advised by its legal advisers would be unlawful under the laws of Jersey or is otherwise not permitted pursuant to the Articles.

4. Exceptions to Indemnification. The Indemnitee shall be entitled to indemnification under Section 3, provided, however, that the Company shall not indemnify or advance Expenses to Indemnitee with respect to any act, event or circumstance with respect to which it is prohibited to do so under applicable law (including the Companies Law) or the Articles. Further the indemnity in Section 3 shall not apply to any liability incurred by the Indemnitee (i) in defending any criminal action or proceeding in which the Indemnitee is convicted, except to the extent it is determined by the Board, in its reasonable opinion, that the Indemnitee had reasonable cause to believe that the Indemnitee’s action was lawful; (ii) in connection with any application pursuant to section 212 of the Companies Law (a “Relevant Application”) in which the court refuses to grant the Indemnitee relief; (iii) in the event that the liability incurred by the Indemnitee is, in the reasonable opinion of the Board, a result of fraud or wilful misconduct by the Indemnitee; or (iv) in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (a) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (b) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law and the Articles. The Company and the Indemnitee acknowledge and agree that nothing in this Section 4 shall preclude the Indemnitee from making claims against the Company to enforce the Indemnitee’s rights under this Agreement.

5. Procedure for Payment of Indemnifiable Amounts. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Amounts for which the Indemnitee seeks payment under Section 3 of this Agreement and a reasonable description of the basis for the claim, including therein or therewith such documentation and information as are reasonably available to the Indemnitee and necessary to establish that the Indemnitee is entitled to indemnification hereunder. Subject to the provisions of this Agreement, the Company shall pay such Indemnifiable Amounts to the Indemnitee within thirty (30) calendar days of receipt of the request.

 

3


Exhibit 10.1

 

6. Indemnification for Expenses if Indemnitee is Wholly or Partly Successful. Notwithstanding anything contained in this Agreement to the contrary, to the extent that the Indemnitee is, by reason of the Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise, in any Proceeding, the Indemnitee shall, subject always to the provisions of the Companies Law and the Articles, be indemnified against all Indemnifiable Amounts in connection therewith. If the Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall subject always to the provisions of the Companies Law and the Articles indemnify the Indemnitee against all Indemnifiable Amounts in connection with each successfully resolved claim, issue or matter and the Board shall address each unsuccessfully resolved claim, issue or matter in its reasonable discretion. For purposes of this Agreement, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. Notwithstanding any of the foregoing, nothing in this Section 6 shall be construed to limit an Indemnitee’s right to indemnification which he or she would otherwise be entitled to pursuant to Section 3 hereof, regardless of the Indemnitee’s success in a Proceeding.

7. Effect of Certain Resolutions. Subject to the provisions of Section 11, neither the settlement or termination of any Proceeding nor the failure of the Company to award indemnification or to determine that indemnification is payable shall create an adverse presumption that the Indemnitee is not entitled to indemnification hereunder. In addition, subject to the provisions of Section 11, the termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not create a presumption that the Indemnitee did not act in good faith and in a manner which the Indemnitee reasonably believed to be in the best interests of the Company or, with respect to any criminal action or proceeding, had reasonable cause to believe that the Indemnitee’s action was unlawful.

8. Agreement to Advance Expenses; Conditions.

(a) Subject to the Companies Law and the provisions of this Agreement, the Company will fund all of the legal and other expenses (“Defence Costs”) properly incurred or to be properly incurred by the Indemnitee in defending any criminal or civil proceedings in connection with any alleged negligence, default, breach of duty or breach of trust by him or her in relation to the Company or in connection with any Relevant Application. Any request for funding under this Section 8 shall be made in writing by the Indemnitee to the Company and determined by resolution of the Board, subject to such conditions as the Board thinks fit.

(b) Any funding provided to the Indemnitee pursuant to this Section 8 shall be treated as an advance (and not a loan that would prohibited under the securities laws of the United States of America) from the Company to the Indemnitee repayable on demand and otherwise on the terms set out in Section 8(c) and Section 8(d), together with such further terms as may be determined by the Board and the Indemnitee at the time of the advance.

(c) The terms are that if the Company provides funds to the Indemnitee in respect of Defence Costs arising in relation to criminal proceedings in which the Indemnitee is subsequently convicted or civil proceedings in which judgment is

 

4


Exhibit 10.1

 

subsequently given against the Indemnitee or a Relevant Application in which the court subsequently refuses to grant the Indemnitee relief, then any obligation of the Company to make further contributions towards the Indemnitee’s Defence Costs shall cease and any amounts already advanced by the Company must be repaid not later than the date that the conviction, judgment or refusal to grant relief becomes final .

(d) In the event that the liability to which the advance relates can properly be discharged by way of indemnity in accordance with Section 3, the obligation to repay such advance will be discharged by way of indemnity in accordance with said Section 3. If the advance is not capable of being discharged by way of indemnity in accordance with the terms of this Agreement (or if the indemnity is insufficient to discharge the full amount of the advance because part of the advance cannot properly be discharged in that way), the advance (or the relevant part of it) shall be repayable by the Indemnitee on demand by the Company.

(e) For the purposes of this Section 8(c), a conviction, judgment or refusal of relief becomes final:

(i) if not appealed against, at the end of the period for bringing an appeal; or

(ii) if appealed against, at the time when the appeal (or any further appeal) is determined and the period for bringing any further appeal has ended or if the appeal is abandoned or otherwise ceases to have effect.

(f) The Indemnitee shall take all reasonable action to mitigate any loss suffered by him or her in respect of such Defence Costs.

9. Procedure for Advance Payment of Expenses. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Expenses for which the Indemnitee seeks an advancement under Section 8 of this Agreement. Subject to the terms of this Agreement, payment of Indemnifiable Expenses under Section 8 shall be made no later than thirty (30) calendar days after the Company’s approval of such request and on the terms set out in Section 8(b). At the request of the Company, the Indemnitee shall furnish such documentation and information as are reasonably available to the Indemnitee in connection with such advancement.

10. Remedies of Indemnitees.

(a) Right to Petition Court. In the event that the Indemnitee makes a request for payment of Indemnifiable Amounts under Section 3 and Section 5 herein or a request for an advancement of Indemnifiable Expenses under Section 8 and Section 9 herein and the Company fails to make such payment or advancement in a timely manner pursuant to the terms of this Agreement, the Indemnitee may petition a court to enforce the Company’s obligations under this Agreement.

(b) Expenses. Subject always to the provisions of the Articles and the Companies Law, the Company agrees to reimburse the Indemnitee in full for any Expenses incurred by the Indemnitee in connection with investigating, preparing for, litigating,

 

5


Exhibit 10.1

 

defending or settling any action brought by the Indemnitee under Section 10(a) above; provided, however, that if the Indemnitee is unsuccessful on the merits in such action, then the Company shall have no obligation to the Indemnitee under this Section 10(b).

(c) Failure to Act Not a Defence. The failure of the Company (including the Board or any committee thereof, independent legal counsel, or shareholders) to make a determination concerning the permissibility of the payment of Indemnifiable Amounts or the advancement of Indemnifiable Expenses under this Agreement shall not be a defence in any action brought under Section 10(a) above, and shall not create a presumption that such payment or advancement is not permissible.

11. Notice by Indemnitee. The Indemnitee agrees to notify the Company promptly upon being served with any summons, citation, subpoena, complaint, indictment, information, or other document relating to, or becoming aware of any circumstances which may lead to, any Proceeding which may result in the payment of Indemnifiable Amounts or the advancement of Indemnifiable Expenses hereunder; provided, however, that the failure to give any such notice shall not disqualify the Indemnitee from the right to receive payments of Indemnifiable Amounts or advancements of Indemnifiable Expenses unless and only to the extent that such failure or delay materially prejudices the Company.

(a) In addition, the Indemnitee shall:

(i) as soon as practicable, give written notice of such circumstances to the Company;

(ii) keep the Company informed of any developments in relation to such circumstances (including by promptly providing the Company with such information and copies of such documents as the Company may reasonably request) and consult the Company regarding the conduct of any claim arising in connection with such circumstances;

(iii) not make any admission of liability, agreement, settlement or compromise with any person in relation to any such circumstances without the prior written consent of the Company (such consent not to be unreasonably withheld or delayed);

(iv) allow the Company at any stage and at its sole discretion to take the sole conduct of and/or settle such actions the Company may deem appropriate in relation to any such circumstances and the Company shall be under no obligation in this respect to notify the Indemnitee of its decision so to settle such action(s); and

(v) take all reasonable action to mitigate any loss suffered by him or her in respect of such Indemnifiable Amounts or Indemnifiable Expenses.

(b) In the event that the Company makes any payment pursuant to this Agreement, the Company shall, save as set out in Section 3(d), be subrogated to the extent of such payment to all of the Indemnitee’s rights of recovery against third parties (including

 

6


Exhibit 10.1

 

any claim under any applicable directors’ and officers’ insurance policy) in respect of the payment and the Indemnitee shall do everything that may be necessary to secure any rights including (but not restricted to):

(i) the execution of any documents necessary to enable the Company effectively to bring an action in the name of the Indemnitee; and

(ii) the provision of assistance as a witness.

(c) If the Company makes any payment to or for the benefit of the Indemnitee pursuant to this Agreement and the Indemnitee subsequently recovers or becomes entitled to recover from a third party any amount which is referable to any part of the liability for which payment was made by the Company, the Indemnitee shall immediately repay or procure the repayment to the Company of so much of the amount paid by the Company as does not exceed the amount recovered (or entitled to be recovered) by the Indemnitee, less any reasonable costs and expenses incurred by the Indemnitee in effecting any such recovery which are not recoverable from any third party.

(d) The Indemnitee shall not be entitled to recover more than once whether pursuant to this Agreement or otherwise in respect of any matter giving rise to a liability.

(e) Except as provided in Section 3(d) above, the Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that the Indemnitee has otherwise actually received such payment under any insurance policy, contract agreement or otherwise.

12. Representations and Warranties of the Company. The Company hereby represents and warrants to the Indemnitee as follows:

(a) Authority. The Company has all necessary power and authority to enter into, and be bound by the terms of, this Agreement, and the execution, delivery and performance of the undertakings contemplated by this Agreement have been duly authorized by the Company.

(b) Enforceability. This Agreement, when executed and delivered by the Company in accordance with the provisions hereof, shall be a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by the Companies Law, the Articles, equitable principles, applicable bankruptcy, désastre, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally.

 

7


Exhibit 10.1

 

13. Contract Rights Not Exclusive; Survival of Rights; Insurance.

(a) The rights to payment of Indemnifiable Amounts and advancement of Indemnifiable Expenses provided by this Agreement shall, subject always to the provisions of the Companies Law and the Articles be in addition to, but not exclusive of, any other rights which the Indemnitee may have at any time under applicable law, the Articles, or any other agreement, vote of shareholders or directors (or a committee of directors), or otherwise, both as to action in the Indemnitee’s official capacity and as to action in any other capacity as a result of the Indemnitee’s serving as a director of the Company. For the avoidance of doubt, subject always to the provisions of the Companies Law and the Articles, it is the intent of this Agreement to cover all actions of the Indemnitee even if such acts occurred prior to the effective date of this Agreement. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of the Indemnitee under this Agreement in respect of any action taken or omitted by the Indemnitee in the Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

(b) The Indemnitee shall be covered by the directors’ and officers’ liability insurance and any other insurance policy or policies providing liability insurance for directors, officers, employees, or agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which such person serves at the written request of the Company, and the Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee, agent or fiduciary under such policy or policies.

14. Successors. This Agreement shall be (a) binding upon all successors and assigns of the Company and (b) binding on and shall inure to the benefit of the heirs, personal representatives, executors and administrators of the Indemnitee. This Agreement shall continue for the benefit of the Indemnitee and such heirs, personal representatives, executors and administrators after the Indemnitee has ceased to have Corporate Status.

15. Change in Law. To the extent that a change in the law of Jersey (whether by statute or judicial decision) shall permit broader indemnification or advancement of expenses properly incurred or paid by the Indemnitee by reason of the Indemnitee’s Corporate Status than is provided under the terms of the Articles and this Agreement, the Indemnitee shall be entitled to such broader indemnification and advancements, and this Agreement shall be deemed to be amended to such extent.

16. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement, or any clause thereof, shall be determined by a court of competent jurisdiction to be illegal, invalid or unenforceable, in whole or in part, such provision or clause shall be limited

 

8


Exhibit 10.1

 

or modified in its application to the minimum extent necessary to make such provision or clause valid, legal and enforceable, and the remaining provisions and clauses of this Agreement shall remain fully enforceable and binding on the parties.

17. Modifications, Remedies and Waiver.

(a) Except as provided in Section 15 above with respect to changes in the law of Jersey which broaden the right of the Indemnitee to be indemnified by the Company against expenses properly incurred or paid by the Indemnitee by reason of the Indemnitee’s Corporate Status, no supplement, modification or amendment of this Agreement shall be binding unless executed in writing by each of the parties hereto.

(b) No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement (whether or not similar), nor shall such waiver constitute a continuing waiver.

(c) No delay or omission by either party to this Agreement in exercising any right, power or remedy provided by law or under this Agreement shall:

(i) affect that right, power or remedy; or

(ii) operate as a waiver of it.

(d) The single or partial exercise of any right, power or remedy provided by law or under this Agreement shall not preclude any other or further exercise of it or the exercise of any other right, power or remedy.

(e) The rights, powers and remedies provided in this Agreement are cumulative and not exclusive of any rights, powers and remedies provided by law.

18. General Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered by hand, (b) when transmitted by facsimile and receipt is acknowledged, or (c) if mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed

(i) If to the Indemnitee, to:

 

 

 

   
 

 

   
 

 

   

 

9


Exhibit 10.1

 

(ii) If to the Company, to:

Mimecast Limited

1 Finsbury Avenue

London EC2M 2PF United Kingdom

Attn: General Counsel

With a copy to:

Mimecast Limited

c/o Mimecast North America, Inc.

191 Spring Street

Lexington, Massachusetts 02421

United States of America

Attn: Legal Department

or to such other address as may have been furnished in the same manner by any party to the others.

19. Assignment.

(a) The Company may at any time assign all or any part of the benefit of, or its rights or benefits under, this Agreement.

(b) The Indemnitee shall not assign, or purport to assign, all or any part of the benefit of, or his rights or benefits under, this Agreement, provided that, in accordance with Section 14, the benefit of, and rights under, this Agreement shall inure to the benefit of the heirs, personal representatives, executors and administrators of the Indemnitee.

20. Entire Agreement

This Agreement, the Articles and, subject to Section 1(l), any provision of any employment contract or terms of appointment under which the Indemnitee is, or is entitled to be, indemnified by the Company, constitute the whole and only agreement between the parties relating to the indemnification of the Indemnitee by the Company and the obligations of the parties in relation to Indemnifiable Amounts or Indemnifiable Expenses.

21. Counterparts.

(a) This Agreement may be executed in any number of counterparts, and by the parties on separate counterparts, but shall not be effective until each party has executed at least one counterpart.

(b) Each counterpart shall constitute an original of this Agreement, but all the counterparts shall together constitute but one and the same instrument.

 

10


Exhibit 10.1

 

22. Limitations on Indemnity. Without prejudice to any other rights or remedies which may be available to the Indemnitee, any indemnity granted by the Company to the Indemnitee under this Agreement shall not apply to the extent that it is not permitted by, or consistent with, law or statute from time to time in force (including, without limitation, the Companies Law), the memorandum and Articles of the Company or the rules and regulations of any regulatory body.

23. Governing Law. This agreement and any dispute or claim arising out of, or in connection with, it or its subject matter or formation (including any dispute or claim relating to non-contractual obligations) shall be governed by and construed in accordance with the laws of the State of Delaware (USA).

24. Jurisdiction. The parties irrevocably agree that the federal and state courts located in the State of Delaware (USA) have exclusive jurisdiction to settle any dispute or claim arising out of, or in connection with, this agreement or its subject matter or formation (including any dispute or claim relating to non-contractual obligations).

[END OF TEXT; SIGNATURE PAGE FOLLOWS]

 

11


Exhibit 10.1

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

 

COMPANY:

MIMECAST LIMITED

By:  

 

 

Name: Peter Bauer

 

Title: Chief Executive Officer

 

INDEMNITEE:

 

Name:

 

[SIGNATURE PAGE TO DIRECTOR INDEMNIFICATION AGREEMENT]

 

12

EX-10.2 3 d39688dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

OFFICER INDEMNIFICATION AGREEMENT

THIS OFFICER INDEMNIFICATION AGREEMENT (this “Agreement”) is made effective as of the      day of                     ,             , by and between MIMECAST LIMITED, a public limited company incorporated in Jersey, Channel Islands under number 119119 the registered office of which is 22 Grenville Street, St Helier, Jersey JE4 8PX (“Company”) and                      (the “Indemnitee”).

WHEREAS, the Indemnitee is an officer of the Company (but not a director of the Company) by virtue of the Indemnitee’s Position or as designated by the Board (as defined below);

WHEREAS, it is essential to the Company that it be able to retain and attract as officers the most capable persons available;

WHEREAS, the Company desires to provide the Indemnitee with specific contractual assurance of the Indemnitee’s rights to indemnification against certain litigation risks and expenses subject always to applicable law.

NOW, THEREFORE, in consideration of the promises and the covenants contained herein, the Company and the Indemnitee do hereby covenant and agree as follows:

1. Definitions and Interpretation.

(a) “Articles” means the Company’s articles of association in force from time to time.

(b) “Board” means the board of directors of the Company.

(c) “Companies Law” means the Companies (Jersey) Law 1991 (as the same may be amended, modified, supplemented or restated from time to time).

(d) “Entity” shall mean any corporation, partnership, limited liability company, joint venture, company, foundation, association, organization or other legal entity.

(e) “Expenses” shall mean all fees, costs and expenses properly incurred in connection with any Proceeding, including, without limitation, attorneys’ fees, disbursements and retainers (including, without limitation, any fees, disbursements and retainers properly incurred by the Indemnitee pursuant to Section 10 of this Agreement), fees and disbursements of expert witnesses, private investigators and professional advisors (including, without limitation, accountants and investment bankers), court costs, transcript costs, fees of experts, travel expenses, duplicating, printing and binding costs, telephone and fax transmission charges, postage, delivery services, secretarial services and other disbursements and expenses.

(f) “Indemnifiable Expenses,” “Indemnifiable Liabilities” and “Indemnifiable Amounts” shall have the meanings ascribed to those terms in Section 3(a) below.


(g) “Indemnitee’s Position” means the Indemnitee’s current or former position as the                      of the Company and, to the extent applicable, the Indemnitee’s position as an officer or director of any Subsidiary of the Company (as defined below).

(h) “Liabilities” shall mean judgments, damages, liabilities, losses, penalties, excise taxes, fines and amounts paid in settlement.

(i) “Proceeding” shall mean any threatened or pending claim, action, suit, arbitration, alternate dispute resolution process, investigation, administrative hearing, appeal, or any other proceeding, whether civil, criminal, administrative, regulatory, arbitrative or investigative, whether formal or informal, including a proceeding initiated by the Indemnitee pursuant to Section 10 of this Agreement to enforce the Indemnitee’s rights hereunder.

(j) “Subsidiary” shall mean any subsidiary of the Company, as defined in the Companies Law.

(k) References to Sections are to sections of this Agreement.

(l) Use of any gender includes the other genders.

(m) Headings and titles are inserted for convenience only and are to be ignored in the interpretation of this Agreement.

(n) If there is any inconsistency between the provisions of this Agreement and the provisions of any contract of employment or terms of appointment in effect on the date of this Agreement between the Indemnitee and the Company (or any Subsidiary), the provisions of this Agreement shall prevail.

2. Services of Indemnitee. In consideration of the Company’s covenants and commitments hereunder, the Indemnitee agrees to serve or continue to serve as an officer of the Company and as an officer or director of any Subsidiary. However, this Agreement shall not impose any obligation on the Indemnitee or the Company to continue the Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.

3. Agreement to Indemnify. Subject always to the provisions of this Agreement, the Articles, the Companies Law and all other applicable laws, the Company hereby agrees to hold harmless and indemnify the Indemnitee against all Expenses and Liabilities properly incurred or paid by the Indemnitee by reason of the Indemnitee’s Position to the fullest extent permitted by Article 77 of the Companies Law, as amended, and any other applicable law. In furtherance of the foregoing indemnification, and without limiting the generality thereof:

(a) Subject to the exceptions contained in Section 4, Section 6 and Section 8 below, if the Indemnitee was or is a party or is threatened to be made a party to or participant in any Proceeding (other than an action by or in the right of the Company) by reason of the Indemnitee’s Position, the Indemnitee shall be indemnified and held harmless

 

2


by the Company against all Expenses and Liabilities properly incurred or paid by the Indemnitee or on the Indemnitee’s behalf in connection with such Proceeding (referred to herein as “Indemnifiable Expenses” and “Indemnifiable Liabilities,” respectively, and collectively as “Indemnifiable Amounts”).

(b) Subject to the exceptions contained in Section 4, Section 6 and Section 8 below, if the Indemnitee was or is, or is threatened to be made, a party to or participant in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of the Indemnitee’s Position, the Indemnitee shall be indemnified and held harmless by the Company against all Indemnifiable Expenses.

(c) In addition to, and without regard to any limitations on, the indemnification provided for in Sections 3(a) and (b) but subject to the exceptions contained in Section 4, Section 6 and Section 8 below, the Indemnitee shall be indemnified and held harmless by the Company against all Indemnifiable Amounts if, by reason of the Indemnitee’s Position, the Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right of the Company) provided that in no circumstances shall the Company be obligated to make any payment to the Indemnitee that it is advised by its legal advisers would be unlawful under the laws of Jersey or is prohibited by the Articles.

4. Exceptions to Indemnification. The Indemnitee shall be entitled to indemnification under Section 3, provided, however, that the Company shall not indemnify or advance Expenses to Indemnitee with respect to any act, event or circumstance with respect to which it is prohibited to do so under applicable law (including the Companies Law) or the Articles. Further the indemnity in Section 3 shall not apply to any liability incurred by the Indemnitee (i) in defending any criminal action or proceeding in which the Indemnitee is convicted, except to the extent it is determined by the Board, in its reasonable opinion, that the Indemnitee had reasonable cause to believe that the Indemnitee’s action was lawful; (ii) in the event that the liability incurred by the Indemnitee is, in the reasonable opinion of the Board, a result of fraud or wilful misconduct by the Indemnitee; and (iii) in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (a) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (b) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law and the Articles. The Company and the Indemnitee acknowledge and agree that nothing in this Section 4 shall preclude the Indemnitee from making claims against the Company to enforce the Indemnitee’s rights under this Agreement.

5. Procedure for Payment of Indemnifiable Amounts. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Amounts for which the Indemnitee seeks payment under Section 3 of this Agreement and a reasonable description of the basis for the claim, including therein or therewith such documentation and information as are reasonably available to the Indemnitee and necessary to establish that the Indemnitee is entitled to indemnification hereunder. Subject to the provisions of this Agreement, the Company shall pay such Indemnifiable Amounts to the Indemnitee within thirty (30) calendar days of receipt of the request.

 

3


6. Indemnification for Expenses if Indemnitee is Wholly or Partly Successful. Notwithstanding anything contained in this Agreement to the contrary, to the extent that the Indemnitee is, by reason of the Indemnitee’s Position, a party to and is successful, on the merits or otherwise, in any Proceeding, the Indemnitee shall, subject always to the provisions of the Companies Law, the Articles and all other applicable laws, be indemnified against all Indemnifiable Amounts in connection therewith. If the Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall subject always to the provisions of the Companies Law, the Articles, all other applicable laws and this Agreement indemnify the Indemnitee against all Indemnifiable Amounts in connection with each successfully resolved claim, issue or matter and the Board shall address each unsuccessfully resolved claim, issue or matter in its reasonable discretion. For purposes of this Agreement, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. Notwithstanding any of the foregoing, nothing in this Section 6 shall be construed to limit an Indemnitee’s right to indemnification which he or she would otherwise be entitled to pursuant to Section 3 hereof, regardless of the Indemnitee’s success in a Proceeding.

7. Effect of Certain Resolutions. Subject to the provisions of Section 11, neither the settlement or termination of any Proceeding nor the failure of the Company to award indemnification or to determine that indemnification is payable shall create an adverse presumption that the Indemnitee is not entitled to indemnification hereunder. In addition, subject to the provisions of Section 11, the termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not create a presumption that the Indemnitee did not act in good faith and in a manner which the Indemnitee reasonably believed to be in the best interests of the Company or, with respect to any criminal action or proceeding, had reasonable cause to believe that the Indemnitee’s action was unlawful.

8. Agreement to Advance Expenses; Conditions.

(a) Subject to applicable law and the provisions of this Agreement, the Company will fund all of the legal and other expenses (“Defence Costs”) properly incurred or to be properly incurred by the Indemnitee in defending any criminal or civil proceedings in connection with any alleged negligence, default, breach of duty or breach of trust by him or her in relation to the Company, including any Subsidiary. Any request for funding under this Section 8 shall be made in writing by the Indemnitee to the Company and determined by resolution of the Board, subject to such conditions as the Board thinks fit.

(b) Any funding provided to the Indemnitee pursuant to this Section 8 shall be treated as an advance (and not a loan that would be prohibited under the securities laws of the United States of America) from the Company to the Indemnitee repayable on demand and otherwise on the terms set out in Section 8(c) and Section 8(d), together with such further terms as may be determined by the Board and the Indemnitee at the time of the advance.

(c) The terms are that if the Company provides funds to the Indemnitee in respect of Defence Costs arising in relation to criminal proceedings in which the

 

4


Indemnitee is subsequently convicted or civil proceedings in which judgment is subsequently given against the Indemnitee in which the court subsequently refuses to grant the Indemnitee relief, then any obligation of the Company to make further contributions towards the Indemnitee’s Defence Costs shall cease and any amounts already advanced by the Company must be repaid not later than the date that the conviction, judgment or refusal to grant relief becomes final .

(d) In the event that the liability to which the advance relates can properly be discharged by way of indemnity in accordance with Section 3, the obligation to repay such advance will be discharged by way of indemnity in accordance with said Section 3. If the advance is not capable of being discharged by way of indemnity in accordance with the terms of this Agreement (or if the indemnity is insufficient to discharge the full amount of the advance because part of the advance cannot properly be discharged in that way), the advance (or the relevant part of it) shall be repayable by the Indemnitee on demand by the Company.

(e) For the purposes of Section 8(c), a conviction, judgment or refusal of relief becomes final:

(i) if not appealed against, at the end of the period for bringing an appeal; or

(ii) if appealed against, at the time when the appeal (or any further appeal) is determined and the period for bringing any further appeal has ended or if the appeal is abandoned or otherwise ceases to have effect.

(f) The Indemnitee shall take all reasonable action to mitigate any loss suffered by him or her in respect of such Defence Costs.

9. Procedure for Advance Payment of Expenses. The Indemnitee shall submit to the Company a written request specifying the Indemnifiable Expenses for which the Indemnitee seeks an advancement under Section 8 of this Agreement. Subject to the terms of this Agreement, payment of Indemnifiable Expenses under Section 8 shall be made no later than thirty (30) calendar days after the Company’s approval of such request and on the terms set out in Section 8(b). At the request of the Company, the Indemnitee shall furnish such documentation and information as are reasonably available to the Indemnitee in connection with such advancement.

10. Remedies of Indemnitees.

(a) Right to Petition Court. In the event that the Indemnitee makes a request for payment of Indemnifiable Amounts under Section 3 and Section 5 herein or a request for an advancement of Indemnifiable Expenses under Sections 8 and Section 9 herein and the Company fails to make such payment or advancement in a timely manner pursuant to the terms of this Agreement, the Indemnitee may petition a court to enforce the Company’s obligations under this Agreement.

(b) Expenses. Subject always to the provisions of the Articles and the Companies Law, the Company agrees to reimburse the Indemnitee in full for any Expenses

 

5


incurred by the Indemnitee in connection with investigating, preparing for, litigating, defending or settling any action brought by the Indemnitee under Section 10(a) above; provided, however, that if the Indemnitee is unsuccessful on the merits in such action, then the Company shall have no obligation to the Indemnitee under this Section 10(b).

(c) Failure to Act Not a Defence. The failure of the Company (including the Board or any committee thereof, independent legal counsel, or shareholders) to make a determination concerning the permissibility of the payment of Indemnifiable Amounts or the advancement of Indemnifiable Expenses under this Agreement shall not be a defence in any action brought under Section 10(a) above, and shall not create a presumption that such payment or advancement is not permissible.

11. Notice by Indemnitee. The Indemnitee agrees to notify the Company promptly upon being served with any summons, citation, subpoena, complaint, indictment, information, or other document relating to, or becoming aware of any circumstances which may lead to, any Proceeding which may result in the payment of Indemnifiable Amounts or the advancement of Indemnifiable Expenses hereunder; provided, however, that the failure to give any such notice shall not disqualify the Indemnitee from the right to receive payments of Indemnifiable Amounts or advancements of Indemnifiable Expenses unless and only to the extent that such failure or delay materially prejudices the Company.

(a) In addition, the Indemnitee shall:

(i) as soon as practicable, give written notice of such circumstances to the Company;

(ii) keep the Company informed of any developments in relation to such circumstances (including by promptly providing the Company with such information and copies of such documents as the Company may reasonably request) and consult the Company regarding the conduct of any claim arising in connection with such circumstances;

(iii) not make any admission of liability, agreement, settlement or compromise with any person in relation to any such circumstances without the prior written consent of the Company (such consent not to be unreasonably withheld or delayed);

(iv) allow the Company at any stage and at its sole discretion to take the sole conduct of and/or settle such actions the Company may deem appropriate in relation to any such circumstances and the Company shall be under no obligation in this respect to notify the Indemnitee of its decision so to settle such action(s); and

(v) take all reasonable action to mitigate any loss suffered by him or her in respect of such Indemnifiable Amounts or Indemnifiable Expenses.

(b) In the event that the Company makes any payment pursuant to this Agreement, the Company shall be subrogated to the extent of such payment to all of the

 

6


Indemnitee’s rights of recovery against third parties (including any claim under any applicable directors’ and officers’ insurance policy) in respect of the payment and the Indemnitee shall do everything that may be necessary to secure any rights including (but not restricted to):

(i) the execution of any documents necessary to enable the Company effectively to bring an action in the name of the Indemnitee; and

(ii) the provision of assistance as a witness.

(c) If the Company makes any payment to or for the benefit of the Indemnitee pursuant to this Agreement and the Indemnitee subsequently recovers or becomes entitled to recover from a third party any amount which is referable to any part of the liability for which payment was made by the Company, the Indemnitee shall immediately repay or procure the repayment to the Company of so much of the amount paid by the Company as does not exceed the amount recovered (or entitled to be recovered) by the Indemnitee, less any reasonable costs and expenses incurred by the Indemnitee in effecting any such recovery which are not recoverable from any third party.

(d) The Indemnitee shall not be entitled to recover more than once whether pursuant to this Agreement or otherwise in respect of any matter giving rise to a liability.

(e) The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that the Indemnitee has otherwise actually received such payment under any insurance policy, contract agreement or otherwise.

12. Representations and Warranties of the Company. The Company hereby represents and warrants to the Indemnitee as follows:

(a) Authority. The Company has all necessary power and authority to enter into, and be bound by the terms of, this Agreement, and the execution, delivery and performance of the undertakings contemplated by this Agreement have been duly authorized by the Company.

(b) Enforceability. This Agreement, when executed and delivered by the Company in accordance with the provisions hereof, shall be a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by the Companies Law, the Articles, equitable principles, applicable bankruptcy, désastre, insolvency, moratorium, reorganization or similar laws affecting the enforcement of creditors’ rights generally.

 

7


13. Contract Rights Not Exclusive; Survival of Rights; Insurance.

(a) The rights to payment of Indemnifiable Amounts and advancement of Indemnifiable Expenses provided by this Agreement shall, subject always to the provisions of the Companies Law, the Articles and applicable law be in addition to, but not exclusive of, any other rights which the Indemnitee may have at any time under applicable law, the Articles, or any other agreement, vote of shareholders or directors (or a committee of directors), or otherwise, both as to action in the Indemnitee’s official capacity and as to action in any other capacity as a result of the Indemnitee’s serving as an officer of the Company or an officer or director of any Subsidiary. For the avoidance of doubt, subject always to the provisions of the Companies Law, the Articles and applicable law it is the intent of this Agreement to cover actions of the Indemnitee even if such acts occurred prior to the effective date of this Agreement. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of the Indemnitee under this Agreement in respect of any action taken or omitted by the Indemnitee in the Indemnitee’s Position prior to such amendment, alteration or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

(b) The Indemnitee shall be covered by the directors’ and officers’ liability insurance and any other insurance policy or policies providing liability insurance for directors, officers, employees, or agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise which such person serves at the written request of the Company, and the Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee, agent or fiduciary under such policy or policies.

14. Successors. This Agreement shall be (a) binding upon all successors and assigns of the Company and (b) binding on and shall inure to the benefit of the heirs, personal representatives, executors and administrators of the Indemnitee. This Agreement shall continue for the benefit of the Indemnitee and such heirs, personal representatives, executors and administrators after the Indemnitee has ceased to hold the Indemnitee’s Position.

15. Change in Law. To the extent that a change in the law of Jersey (whether by statute or judicial decision) shall permit broader indemnification or advancement of expenses properly incurred or paid by the Indemnitee by reason of the Indemnitee’s position or otherwise than is provided under the terms of the Articles and this Agreement, the Indemnitee shall be entitled to such broader indemnification and advancements, and this Agreement shall be deemed to be amended to such extent.

16. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement, or any clause thereof, shall be determined by a court of competent jurisdiction

 

8


to be illegal, invalid or unenforceable, in whole or in part, such provision or clause shall be limited or modified in its application to the minimum extent necessary to make such provision or clause valid, legal and enforceable, and the remaining provisions and clauses of this Agreement shall remain fully enforceable and binding on the parties.

17. Modifications, Remedies and Waiver.

(a) Except as provided in Section 15 above with respect to changes in the law of Jersey which broaden the right of the Indemnitee to be indemnified by the Company against expenses properly incurred or paid by the Indemnitee by reason of the Indemnitee’s position or otherwise, no supplement, modification or amendment of this Agreement shall be binding unless executed in writing by each of the parties hereto.

(b) No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement (whether or not similar), nor shall such waiver constitute a continuing waiver.

(c) No delay or omission by either party to this Agreement in exercising any right, power or remedy provided by law or under this Agreement shall:

(i) affect that right, power or remedy; or

(ii) operate as a waiver of it.

(d) The single or partial exercise of any right, power or remedy provided by law or under this Agreement shall not preclude any other or further exercise of it or the exercise of any other right, power or remedy.

(e) The rights, powers and remedies provided in this Agreement are cumulative and not exclusive of any rights, powers and remedies provided by law.

18. General Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered by hand, (b) when transmitted by facsimile and receipt is acknowledged, or (c) if mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed

(i) If to the Indemnitee, to:

 

 

 

   
 

 

   
 

 

   
 

 

   

 

9


(ii) If to the Company, to:

Mimecast Limited

1 Finsbury Square

London EC2M 2PF

United Kingdom

Attn: Peter Bauer

With a copy to:

Mimecast Limited

c/o Mimecast North America, Inc.

191 Spring Street

Lexington, Massachusetts 02421

United States of America

Attn: General Counsel

or to such other address as may have been furnished in the same manner by any party to the others.

19. Assignment.

(a) The Company may at any time assign all or any part of the benefit of, or its rights or benefits under, this Agreement.

(b) The Indemnitee shall not assign, or purport to assign, all or any part of the benefit of, or his rights or benefits under, this Agreement, provided that, in accordance with Section 14, the benefit of, and rights under, this Agreement shall inure to the benefit of the heirs, personal representatives, executors and administrators of the Indemnitee.

20. Entire Agreement

This Agreement, the Articles and, subject to Section 1(m), any provision of any employment contract or terms of appointment under which the Indemnitee is, or is entitled to be, indemnified by the Company, constitute the whole and only agreement between the parties relating to the indemnification of the Indemnitee by the Company and the obligations of the parties in relation to Indemnifiable Amounts or Indemnifiable Expenses.

21. Counterparts.

(a) This Agreement may be executed in any number of counterparts, and by the parties on separate counterparts, but shall not be effective until each party has executed at least one counterpart.

(b) Each counterpart shall constitute an original of this Agreement, but all the counterparts shall together constitute but one and the same instrument.

 

10


22. Limitations on Indemnity. Without prejudice to any other rights or remedies which may be available to the Indemnitee, any indemnity granted by the Company to the Indemnitee under this Agreement shall not apply to the extent that it is not permitted by, or consistent with, law or statute from time to time in force (including, without limitation, the Companies Law), the memorandum and Articles of the Company or the rules and regulations of any regulatory body.

23. Governing Law. This agreement and any dispute or claim arising out of, or in connection with, it or its subject matter or formation (including any dispute or claim relating to non-contractual obligations) shall be governed by and construed in accordance with the laws of the State of Delaware (USA).

24. Jurisdiction. The parties irrevocably agree that the state and federal courts located in the State of Delaware (USA) have exclusive jurisdiction to settle any dispute or claim arising out of, or in connection with, this agreement or its subject matter or formation (including any dispute or claim relating to non-contractual obligations).

[END OF TEXT; SIGNATURE PAGE FOLLOWS]

 

11


IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

 

COMPANY:
MIMECAST LIMITED
By:  

 

  Name: Peter Bauer
  Title: Chief Executive Officer

 

INDEMNITEE:

 

Name:

 

[SIGNATURE PAGE TO OFFICER INDEMNIFICATION AGREEMENT]

 

12

EX-101.SCH 4 mime-20201007.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 mime-20201007_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Tax Identification Number Entity Tax Identification Number Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 6 mime-20201007_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 d39688d8k_htm.xml IDEA: XBRL DOCUMENT 0001644675 2020-10-07 2020-10-07 Mimecast Ltd 00-0000000 false 0001644675 8-K 2020-10-07 Y9 001-37637 1 Finsbury Avenue London EC2M 2PF GB (781) 996-5340 false false false false Ordinary Shares, nominal value $0.012 per share MIME NASDAQ false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information
Oct. 07, 2020
Cover [Abstract]  
Entity Registrant Name Mimecast Ltd
Entity Tax Identification Number 00-0000000
Amendment Flag false
Entity Central Index Key 0001644675
Document Type 8-K
Document Period End Date Oct. 07, 2020
Entity Incorporation State Country Code Y9
Entity File Number 001-37637
Entity Address, Address Line One 1 Finsbury Avenue
Entity Address, City or Town London
Entity Address, Postal Zip Code EC2M 2PF
Entity Address, Country GB
City Area Code (781)
Local Phone Number 996-5340
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Ordinary Shares, nominal value $0.012 per share
Trading Symbol MIME
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d39688d8k.htm d39688dex101.htm d39688dex102.htm mime-20201007.xsd mime-20201007_lab.xml mime-20201007_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d39688d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d39688d8k.htm" ] }, "labelLink": { "local": [ "mime-20201007_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mime-20201007_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mime-20201007.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mime", "nsuri": "http://www.mimecast.com/20201007", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d39688d8k.htm", "contextRef": "duration_2020-10-07_to_2020-10-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d39688d8k.htm", "contextRef": "duration_2020-10-07_to_2020-10-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.mimecast.com//20201007/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001193125-20-266430-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-266430-xbrl.zip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

&UL4$L%!@ & 8 ? $ +YX $! end